CoChat

Epitope prediction and identification—Adaptive T cell responses in humans

Sidney, John, Peters, Bjoern, Sette, Alessandro · 2020 · Seminars in Immunology
Cited by 81

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.smim.2020.101418

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 17 references

Research works printed but not linked: 147

  1. Peters, 2005, The design and implementation of the immune epitope database and analysis resource, Immunogenetics, 57, 326, 10.1007/s00251-005-0803-5 · DOI
  2. Shiromizu, 2018, Gammadelta t lymphocytes: an effector cell in autoimmunity and infection, Front. Immunol., 9, 2389, 10.3389/fimmu.2018.02389 · DOI
  3. Karamooz, 2018, MR1-dependent antigen presentation, Semin. Cell Dev. Biol., 84, 58, 10.1016/j.semcdb.2017.11.028 · DOI
  4. Terabe, 2018, Tissue-specific roles of NKT cells in tumor immunity, Front. Immunol., 9, 1838, 10.3389/fimmu.2018.01838 · DOI
  5. Lepore, 2018, The conventional nature of non-MHC-restricted t cells, Front. Immunol., 9, 1365, 10.3389/fimmu.2018.01365 · DOI
  6. Hinks, 2020, MAIT cell activation and functions, Front. Immunol., 11, 1014, 10.3389/fimmu.2020.01014 · DOI · Paper page
  7. Alfonso, 2000, Nonclassical MHC class II molecules, Annu. Rev. Immunol., 18, 113, 10.1146/annurev.immunol.18.1.113 · DOI · Paper page
  8. Braud, 1999, Functions of nonclassical MHC and non-MHC-encoded class I molecules, Curr. Opin. Immunol., 11, 100, 10.1016/S0952-7915(99)80018-1 · DOI · Paper page
  9. Blum, 2013, Pathways of antigen processing, Annu. Rev. Immunol., 31, 443, 10.1146/annurev-immunol-032712-095910 · DOI · Paper page
  10. Ishioka, 1993, Major histocompatibility complex class II association and induction of T cell responses by carbohydrates and glycopeptides, Springer Semin. Immunopathol., 15, 293
  11. Avci, 2011, A mechanism for glycoconjugate vaccine activation of the adaptive immune system and its implications for vaccine design, Nat. Med., 17, 1602, 10.1038/nm.2535 · DOI · Paper page
  12. Sun, 2020, Glycopeptide epitope facilitates HIV-1 envelope specific humoral immune responses by eliciting T cell help, Nat. Commun., 11, 2550, 10.1038/s41467-020-16319-0 · DOI
  13. Pamer, 1998, Mechanisms of MHC class I--restricted antigen processing, Annu. Rev. Immunol., 16, 323, 10.1146/annurev.immunol.16.1.323 · DOI · Paper page
  14. Rudolph, 2006, How TCRs bind MHCs, peptides, and coreceptors, Annu. Rev. Immunol., 24, 419, 10.1146/annurev.immunol.23.021704.115658 · DOI · Paper page
  15. Rotzschke, 1991, Exact prediction of a natural T cell epitope, Eur. J. Immunol., 21, 2891, 10.1002/eji.1830211136 · DOI · Paper page
  16. Bertoletti, 1993, Definition of a minimal optimal cytotoxic T-cell epitope within the hepatitis B virus nucleocapsid protein, J. Virol., 67, 2376, 10.1128/jvi.67.4.2376-2380.1993 · DOI · Paper page
  17. Hunt, 1992, Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad, Science, 256, 1817, 10.1126/science.1319610 · DOI · Paper page
  18. Lamont, 1990, The use of peptide analogs with improved stability and MHC binding capacity to inhibit antigen presentation in vitro and in vivo, J. Immunol., 144, 2493, 10.4049/jimmunol.144.7.2493 · DOI
  19. Madden, 1995, The three-dimensional structure of peptide-MHC complexes, Annu. Rev. Immunol., 13, 587, 10.1146/annurev.iy.13.040195.003103 · doi:10.1146/annurev.iy.13.040195.003103 · Paper page
  20. Carson, 1997, T cell receptor recognition of MHC class II-bound peptide flanking residues enhances immunogenicity and results in altered TCR V region usage, Immunity, 7, 387, 10.1016/S1074-7613(00)80360-X · DOI · Paper page
  21. Martini, 2020, The immune epitope database and analysis resource program 2003-2018: reflections and outlook, Immunogenetics, 72, 57, 10.1007/s00251-019-01137-6 · DOI
  22. Salimi, 2012, The immune epitope database: a historical retrospective of the first decade, Immunology, 137, 117, 10.1111/j.1365-2567.2012.03611.x · DOI
  23. Vita, 2019, The Immune Epitope Database (IEDB): 2018 update, Nucleic Acids Res., 47, D339, 10.1093/nar/gky1006 · DOI · Paper page
  24. Vita, 2017, Better living through ontologies at the Immune Epitope Database, Database (Oxford), 2017
  25. Peters, 2020, T cell epitope predictions, Annu. Rev. Immunol., 38, 123, 10.1146/annurev-immunol-082119-124838 · DOI · Paper page
  26. Sidney, 2013, Measurement of MHC/peptide interactions by gel filtration or monoclonal antibody capture, Curr. Protoc. Immunol., 10.1002/0471142735.im1803s100 · DOI · Paper page
  27. Paul, 2019, Major histocompatibility complex binding, eluted ligands, and immunogenicity: benchmark testing and predictions, Front. Immunol., 10, 3151, 10.3389/fimmu.2019.03151 · DOI
  28. Gfeller, 2018, Predicting antigen presentation-what could we learn from a million peptides?, Front. Immunol., 9, 1716, 10.3389/fimmu.2018.01716 · DOI · Paper page
  29. Freudenmann, 2018, Mapping the tumour human leukocyte antigen (HLA) ligandome by mass spectrometry, Immunology, 154, 331, 10.1111/imm.12936 · DOI · Paper page
  30. Harndahl, 2012, Peptide-MHC class I stability is a better predictor than peptide affinity of CTL immunogenicity, Eur. J. Immunol., 42, 1405, 10.1002/eji.201141774 · DOI · Paper page
  31. Harndahl, 2011, Real-time, high-throughput measurements of peptide-MHC-I dissociation using a scintillation proximity assay, J. Immunol. Methods, 374, 5, 10.1016/j.jim.2010.10.012 · DOI
  32. Sette, 1987, Structural characteristics of an antigen required for its interaction with Ia and recognition by T cells, Nature, 328, 395, 10.1038/328395a0 · DOI · Paper page
  33. Buus, 1987, The relation between major histocompatibility complex (MHC) restriction and the capacity of Ia to bind immunogenic peptides, Science, 235, 1353, 10.1126/science.2435001 · DOI · Paper page
  34. Sette, 1994, The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes, J. Immunol., 153, 5586, 10.4049/jimmunol.153.12.5586 · DOI · Paper page
  35. Paul, 2020, Benchmarking predictions of MHC class I restricted T cell epitopes in a comprehensively studied model system, PLoS Comput. Biol., 16, 10.1371/journal.pcbi.1007757 · DOI
  36. Wu, 2019, Quantification of epitope abundance reveals the effect of direct and cross-presentation on influenza CTL responses, Nat. Commun., 10, 2846, 10.1038/s41467-019-10661-8 · DOI
  37. Croft, 2019, Most viral peptides displayed by class I MHC on infected cells are immunogenic, Proc. Natl. Acad. Sci. U. S. A., 116, 3112, 10.1073/pnas.1815239116 · DOI
  38. Dhanda, 2018, Predicting HLA CD4 immunogenicity in human populations, Front. Immunol., 9, 1369, 10.3389/fimmu.2018.01369 · DOI · Paper page
  39. Yewdell, 1999, Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses, Annu. Rev. Immunol., 17, 51, 10.1146/annurev.immunol.17.1.51 · DOI · Paper page
  40. Yewdell, 2006, Confronting complexity: real-world immunodominance in antiviral CD8+ T cell responses, Immunity, 25, 533, 10.1016/j.immuni.2006.09.005 · DOI · Paper page
  41. Schaeffer, 1989, Relative contribution of “determinant selection” and “holes in the T-cell repertoire” to T-cell responses, Proc. Natl. Acad. Sci. U. S. A., 86, 4649, 10.1073/pnas.86.12.4649 · DOI
  42. Assarsson, 2007, A quantitative analysis of the variables affecting the repertoire of T cell specificities recognized after vaccinia virus infection, J. Immunol., 178, 7890, 10.4049/jimmunol.178.12.7890 · DOI · Paper page
  43. Klein, 2014, Positive and negative selection of the T cell repertoire: what thymocytes see (and don’t see), Nature reviews, Immunology, 14, 377
  44. Paterson, 2010, Taming tissue-specific T cells: CTLA-4 reins in self-reactive T cells, Nat. Immunol., 11, 109, 10.1038/ni0210-109 · DOI
  45. Pham, 2016, Sequence conservation predicts T cell reactivity against ragweed allergens, Clin. Exp. Allergy, 46, 1194, 10.1111/cea.12772 · DOI
  46. Westernberg, 2016, T-cell epitope conservation across allergen species is a major determinant of immunogenicity, J. Allergy Clin. Immunol., 138, 571, 10.1016/j.jaci.2015.11.034 · DOI
  47. Scriba, 2017, Differential recognition of Mycobacterium tuberculosis-specific epitopes as a function of tuberculosis disease history, Am. J. Respir. Crit. Care Med., 196, 772, 10.1164/rccm.201706-1208OC · DOI
  48. Shah, 2019, Nontuberculous mycobacteria and heterologous immunity to tuberculosis, J. Infect. Dis., 220, 1091, 10.1093/infdis/jiz285 · DOI
  49. Lindestam Arlehamn, 2015, Immunological consequences of intragenus conservation of Mycobacterium tuberculosis T-cell epitopes, Proc. Natl. Acad. Sci. U. S. A., 112, E147, 10.1073/pnas.1416537112 · DOI
  50. Grifoni, 2017, Prior dengue virus exposure shapes t cell immunity to Zika Virus in humans, J. Virol., 91, 10.1128/JVI.01469-17 · DOI · Paper page
  51. Weiskopf, 2015, The human CD8+ T cell responses induced by a live attenuated tetravalent dengue vaccine are directed against highly conserved epitopes, J. Virol., 89, 120, 10.1128/JVI.02129-14 · DOI · Paper page
  52. Grifoni, 2020, T cell responses induced by attenuated flavivirus vaccination are specific and show limited cross-reactivity with other flavivirus species, J. Virol., 94, 10.1128/JVI.00089-20 · DOI · Paper page
  53. Chiu, 2014, Broadly reactive human CD8 T cells that recognize an epitope conserved between VZV, HSV and EBV, PLoS Pathog., 10, 10.1371/journal.ppat.1004008 · DOI
  54. Siciliano, 2014, Impact of distinct poxvirus infections on the specificities and functionalities of CD4+ T cell responses, J. Virol., 88, 10078, 10.1128/JVI.01150-14 · DOI
  55. Walsh, 2009, Diverse recognition of conserved orthopoxvirus CD8+ T cell epitopes in vaccinated rhesus macaques, Vaccine, 27, 4990, 10.1016/j.vaccine.2009.05.077 · DOI
  56. Greenbaum, 2009, Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population, Proc. Natl. Acad. Sci. U. S. A., 106, 20365, 10.1073/pnas.0911580106 · DOI · Paper page
  57. Skevaki, 2018, Influenza-derived peptides cross-react with allergens and provide asthma protection, J. Allergy Clin. Immunol., 142, 804, 10.1016/j.jaci.2017.07.056 · DOI
  58. Bresciani, 2016, T-cell recognition is shaped by epitope sequence conservation in the host proteome and microbiome, Immunology, 148, 34, 10.1111/imm.12585 · doi:10.1111/imm.12585
  59. Carrasco Pro, 2018, Microbiota epitope similarity either dampens or enhances the immunogenicity of disease-associated antigenic epitopes, PLoS One, 13, 10.1371/journal.pone.0196551 · DOI
  60. Laheurte, 2016, Immunoprevalence and magnitude of HLA-DP4 versus HLA-DR-restricted spontaneous CD4(+) Th1 responses against telomerase in cancer patients, Oncoimmunology, 5, 10.1080/2162402X.2015.1137416 · DOI
  61. Oseroff, 2008, Dissociation between epitope hierarchy and immunoprevalence in CD8 responses to vaccinia virus western reserve, J. Immunol., 180, 7193, 10.4049/jimmunol.180.11.7193 · DOI
  62. Moxon, 2019, Editorial: reverse vaccinology, Front. Immunol., 10, 2776, 10.3389/fimmu.2019.02776 · DOI
  63. Moutaftsi, 2010, Uncovering the interplay between CD8, CD4 and antibody responses to complex pathogens, Future Microbiol., 5, 221, 10.2217/fmb.09.110 · DOI
  64. Assarsson, 2008, Kinetic analysis of a complete poxvirus transcriptome reveals an immediate-early class of genes, Proc. Natl. Acad. Sci. U. S. A., 105, 2140, 10.1073/pnas.0711573105 · DOI
  65. Ashburner, 2000, Gene ontology: tool for the unification of biology, Gene Ontol. Consort. Nat. Genet., 25, 25, 10.1038/75556 · DOI · Paper page
  66. Bausch-Fluck, 2015, A mass spectrometric-derived cell surface protein atlas, PLoS One, 10
  67. Bausch-Fluck, 2018, The in silico human surfaceome, Proc. Natl. Acad. Sci. U. S. A., 115, E10988, 10.1073/pnas.1808790115 · DOI · Paper page
  68. Vathipadiekal, 2015, Creation of a human secretome: a novel composite library of human secreted proteins: validation using ovarian Cancer gene expression data and a virtual secretome array, Clin. Cancer Res., 21, 4960, 10.1158/1078-0432.CCR-14-3173 · DOI
  69. Schulten, 2018, Allergen and epitope targets of mouse-specific t cell responses in allergy and asthma, Front. Immunol., 9, 235, 10.3389/fimmu.2018.00235 · DOI
  70. Schulten, 2013, Previously undescribed grass pollen antigens are the major inducers of T helper 2 cytokine-producing T cells in allergic individuals, Proc. Natl. Acad. Sci. U. S. A., 110, 3459, 10.1073/pnas.1300512110 · DOI
  71. Oseroff, 2017, Immunoproteomic analysis of house dust mite antigens reveals distinct classes of dominant T cell antigens according to function and serological reactivity, Clin. Exp. Allergy, 47, 577, 10.1111/cea.12829 · DOI
  72. Lindestam Arlehamn, 2013, Memory T cells in latent Mycobacterium tuberculosis infection are directed against three antigenic islands and largely contained in a CXCR3+CCR6+ Th1 subset, PLoS Pathog., 9, 10.1371/journal.ppat.1003130 · DOI · Paper page
  73. Pearson, 2016, MHC class I-associated peptides derive from selective regions of the human genome, J. Clin. Invest., 126, 4690, 10.1172/JCI88590 · DOI · Paper page
  74. Robinson, 2020, IPD-IMGT/HLA database, Nucleic Acids Res., 48, D948
  75. Greenbaum, 2011, Functional classification of class II human leukocyte antigen (HLA) molecules reveals seven different supertypes and a surprising degree of repertoire sharing across supertypes, Immunogenetics, 63, 325, 10.1007/s00251-011-0513-0 · DOI · Paper page
  76. Sette, 1998, HLA supertypes and supermotifs: a functional perspective on HLA polymorphism, Curr. Opin. Immunol., 10, 478, 10.1016/S0952-7915(98)80124-6 · DOI · Paper page
  77. Sidney, 1995, Several HLA alleles share overlapping peptide specificities, J. Immunol., 154, 247, 10.4049/jimmunol.154.1.247 · DOI · Paper page
  78. Sidney, 1996, Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs, Immunol. Today, 17, 261, 10.1016/0167-5699(96)80542-1 · DOI · Paper page
  79. Sidney, 1996, Definition of an HLA-A3-like supermotif demonstrates the overlapping peptide-binding repertoires of common HLA molecules, Hum. Immunol., 45, 79, 10.1016/0198-8859(95)00173-5 · DOI · Paper page
  80. Sidney, 1996, Specificity and degeneracy in peptide binding to HLA-B7-like class I molecules, J. Immunol., 157, 3480, 10.4049/jimmunol.157.8.3480 · DOI · Paper page
  81. Sidney, 2001, Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules, Hum. Immunol., 62, 1200, 10.1016/S0198-8859(01)00319-6 · DOI
  82. Sidney, 2003, Simultaneous prediction of binding capacity for multiple molecules of the HLA B44 supertype, J. Immunol., 171, 5964, 10.4049/jimmunol.171.11.5964 · DOI
  83. Sidney, 2005, Classification of A1- and A24-supertype molecules by analysis of their MHC-peptide binding repertoires, Immunogenetics, 57, 393, 10.1007/s00251-005-0004-2 · DOI
  84. Southwood, 1998, Several common HLA-DR types share largely overlapping peptide binding repertoires, J. Immunol., 160, 3363, 10.4049/jimmunol.160.7.3363 · DOI · Paper page
  85. Lund, 2004, Definition of supertypes for HLA molecules using clustering of specificity matrices, Immunogenetics, 55, 797, 10.1007/s00251-004-0647-4 · DOI · Paper page
  86. Nielsen, 2010, MHC class II epitope predictive algorithms, Immunology, 130, 319, 10.1111/j.1365-2567.2010.03268.x · DOI · Paper page
  87. Weiskopf, 2013, Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells, Proc. Natl. Acad. Sci. U. S. A., 110, E2046, 10.1073/pnas.1305227110 · DOI · Paper page
  88. Reche, 2005, PEPVAC: a web server for multi-epitope vaccine development based on the prediction of supertypic MHC ligands, Nucleic Acids Res., 33, W138, 10.1093/nar/gki357 · DOI
  89. McKinney, 2013, A strategy to determine HLA class II restriction broadly covering the DR, DP, and DQ allelic variants most commonly expressed in the general population, Immunogenetics, 65, 357, 10.1007/s00251-013-0684-y · DOI · Paper page
  90. Oyarzun, 2015, A bioinformatics tool for epitope-based vaccine design that accounts for human ethnic diversity: application to emerging infectious diseases, Vaccine, 33, 1267, 10.1016/j.vaccine.2015.01.040 · DOI
  91. Nepom, 2012, MHC class II tetramers, J. Immunol., 188, 2477, 10.4049/jimmunol.1102398 · DOI · Paper page
  92. Nepom, 2002, HLA class II tetramers: tools for direct analysis of antigen-specific CD4+ T cells, Arthritis Rheum., 46, 5, 10.1002/1529-0131(200201)46:1<5::AID-ART10063>3.0.CO;2-S · doi:10.1002/1529-0131(200201)46:1<5::aid-art10063>3.0.co;2-s
  93. Cecconi, 2008, Use of MHC class II tetramers to investigate CD4+ T cell responses: problems and solutions, Cytometry A, 73, 1010, 10.1002/cyto.a.20603 · DOI
  94. Christophersen, 2020, Peptide-MHC class I and class II tetramers: from flow to mass cytometry, HLA, 95, 169, 10.1111/tan.13789 · DOI
  95. Bui, 2006, Predicting population coverage of T-cell epitope-based diagnostics and vaccines, BMC Bioinformatics, 7, 153, 10.1186/1471-2105-7-153 · DOI · Paper page
  96. Liu, 2020, Computationally optimized SARS-CoV-2 MHC class I and II vaccine formulations predicted to target human haplotype distributions, Cell Syst., 10.1016/j.cels.2020.06.009 · DOI
  97. Panina-Bordignon, 1989, Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells, Eur. J. Immunol., 19, 2237, 10.1002/eji.1830191209 · DOI · Paper page
  98. Sinigaglia, 1988, A malaria T-cell epitope recognized in association with most mouse and human MHC class II molecules, Nature, 336, 778, 10.1038/336778a0 · DOI · Paper page
  99. Busch, 1990, Degenerate binding of immunogenic peptides to HLA-DR proteins on B cell surfaces, Int. Immunol., 2, 443, 10.1093/intimm/2.5.443 · DOI
  100. Roche, 1990, High-affinity binding of an influenza hemagglutinin-derived peptide to purified HLA-DR, J. Immunol., 144, 1849, 10.4049/jimmunol.144.5.1849 · doi:10.4049/jimmunol.144.5.1849
  101. O’Sullivan, 1991, Truncation analysis of several DR binding epitopes, J. Immunol., 146, 1240, 10.4049/jimmunol.146.4.1240 · doi:10.4049/jimmunol.146.4.1240
  102. O’Sullivan, 1990, Characterization of the specificity of peptide binding to four DR haplotypes, J. Immunol., 145, 1799, 10.4049/jimmunol.145.6.1799 · doi:10.4049/jimmunol.145.6.1799
  103. Alexander, 1994, Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides, Immunity, 1, 751, 10.1016/S1074-7613(94)80017-0 · DOI · Paper page
  104. Oseroff, 2010, Molecular determinants of T cell epitope recognition to the common Timothy grass allergen, J. Immunol., 185, 943, 10.4049/jimmunol.1000405 · DOI · Paper page
  105. Oseroff, 2012, Analysis of T cell responses to the major allergens from German cockroach: epitope specificity and relationship to IgE production, J. Immunol., 189, 679, 10.4049/jimmunol.1200694 · DOI
  106. Oseroff, 2012, T cell responses to known allergen proteins are differently polarized and account for a variable fraction of total response to allergen extracts, J. Immunol., 189, 1800, 10.4049/jimmunol.1200850 · DOI
  107. Vita, 2008, The curation guidelines of the immune epitope database and analysis resource, Cytometry A, 73, 1066, 10.1002/cyto.a.20585 · DOI · Paper page
  108. Brodsky, 1979, Monoclonal antibodies for analysis of the HLA system, Immunol. Rev., 47, 3, 10.1111/j.1600-065X.1979.tb00288.x · DOI · Paper page
  109. McMichael, 1980, HLA restriction of human cytotoxic T cells, Springer Semin. Immunopathol., 3, 3, 10.1007/BF00199923 · doi:10.1007/bf00199923
  110. Wang, 2009, Molecular cloning and characterization of MHC class I- and II-restricted tumor antigens recognized by T cells, Curr. Protoc. Immunol., 10.1002/0471142735.im2010s84 · DOI
  111. Wilson, 2001, Identification and antigenicity of broadly cross-reactive and conserved human immunodeficiency virus type 1-derived helper T-lymphocyte epitopes, J. Virol., 75, 4195, 10.1128/JVI.75.9.4195-4207.2001 · DOI
  112. Lamb, 1982, Antigen-specific human T lymphocyte clones: induction, antigen specificity, and MHC restriction of influenza virus-immune clones, J. Immunol., 128, 233, 10.4049/jimmunol.128.1.233 · doi:10.4049/jimmunol.128.1.233
  113. Paul, 2017, Experimental validation of the RATE tool for inferring HLA restrictions of T cell epitopes, BMC Immunol., 18, 20, 10.1186/s12865-017-0204-1 · DOI
  114. Paul, 2015, A population response analysis approach to assign class II HLA-epitope restrictions, J. Immunol., 194, 6164, 10.4049/jimmunol.1403074 · DOI · Paper page
  115. Altman, 2003, MHC-peptide tetramers to visualize antigen-specific T cells, Curr. Protoc. Immunol., 10.1002/0471142735.im1703s53 · DOI
  116. Bakker, 2005, MHC multimer technology: current status and future prospects, Curr. Opin. Immunol., 17, 428, 10.1016/j.coi.2005.06.008 · DOI
  117. Ihantola, 2020, Characterization of proinsulin t cell epitopes restricted by type 1 diabetes-associated HLA class II molecules, J. Immunol., 204, 2349, 10.4049/jimmunol.1901079 · DOI
  118. Surenaud, 2019, Anti-HIV potency of T-cell responses elicited by dendritic cell therapeutic vaccination, PLoS Pathog., 15, 10.1371/journal.ppat.1008011 · DOI
  119. Lindestam Arlehamn, 2016, A quantitative analysis of complexity of human pathogen-specific CD4 t cell responses in healthy M. Tuberculosis infected south africans, PLoS Pathog., 12, 10.1371/journal.ppat.1005760 · DOI · Paper page
  120. Campbell, 2020, Proteome-wide zika virus CD4 t cell epitope and HLA restriction determination, Immunohorizons, 4, 444, 10.4049/immunohorizons.2000068 · DOI
  121. Kotturi, 2007, The CD8+ T-cell response to lymphocytic choriomeningitis virus involves the L antigen: uncovering new tricks for an old virus, J. Virol., 81, 4928, 10.1128/JVI.02632-06 · DOI · Paper page
  122. Geiger, 2009, Human naive and memory CD4+ T cell repertoires specific for naturally processed antigens analyzed using libraries of amplified T cells, J. Exp. Med., 206, 1525, 10.1084/jem.20090504 · DOI · Paper page
  123. Koelle, 2003, Expression cloning for the discovery of viral antigens and epitopes recognized by T cells, Methods, 29, 213, 10.1016/S1046-2023(02)00344-4 · doi:10.1016/s1046-2023(02)00344-4
  124. Czerkinsky, 1983, A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells, J. Immunol. Methods, 65, 109, 10.1016/0022-1759(83)90308-3 · DOI · Paper page
  125. Pala, 2000, Flow cytometric measurement of intracellular cytokines, J. Immunol. Methods, 243, 107, 10.1016/S0022-1759(00)00230-1 · DOI · Paper page
  126. Havenar-Daughton, 2016, Cytokine-independent detection of antigen-specific germinal center t follicular helper cells in immunized nonhuman Primates Using a live cell activation-induced marker technique, J. Immunol., 197, 994, 10.4049/jimmunol.1600320 · DOI · Paper page
  127. Dan, 2016, A cytokine-independent approach to identify antigen-specific human germinal center t follicular helper cells and rare antigen-specific CD4+ t cells in blood, J. Immunol., 197, 983, 10.4049/jimmunol.1600318 · DOI · Paper page
  128. Dan, 2019, Recurrent group A Streptococcus tonsillitis is an immunosusceptibility disease involving antibody deficiency and aberrant TFH cells, Sci. Transl. Med., 11, 10.1126/scitranslmed.aau3776 · DOI
  129. Morou, 2019, Altered differentiation is central to HIV-specific CD4(+) T cell dysfunction in progressive disease, Nat. Immunol., 20, 1059, 10.1038/s41590-019-0418-x · DOI · Paper page
  130. Paul, 2015, Development and validation of a broad scheme for prediction of HLA class II restricted T cell epitopes, J. Immunol. Methods, 422, 28, 10.1016/j.jim.2015.03.022 · DOI · Paper page
  131. Carrasco Pro, 2015, Automatic generation of validated specific epitope sets, J. Immunol. Res., 2015, 10.1155/2015/763461 · DOI · Paper page
  132. da Silva Antunes, 2020, Development and validation of a Bordetella pertussis whole-genome screening strategy, J. Immunol. Res., 2020, 10.1155/2020/8202067 · DOI
  133. da Silva Antunes, 2017, Definition of human epitopes recognized in tetanus toxoid and development of an assay strategy to detect ex vivo tetanus CD4+ t cell responses, PLoS One, 12, 10.1371/journal.pone.0169086 · DOI · Paper page
  134. Hinz, 2015, Definition of a pool of epitopes that recapitulates the T cell reactivity against major house dust mite allergens, Clin. Exp. Allergy, 45, 1601, 10.1111/cea.12507 · DOI
  135. Hinz, 2016, Lack of allergy to timothy grass pollen is not a passive phenomenon but associated with the allergen-specific modulation of immune reactivity, Clin. Exp. Allergy, 46, 705, 10.1111/cea.12692 · DOI
  136. Grifoni, 2017, Global assessment of dengue virus-specific CD4(+) t cell responses in dengue-endemic areas, Front. Immunol., 8, 1309, 10.3389/fimmu.2017.01309 · DOI · Paper page
  137. Weiskopf, 2015, Human CD8+ T-Cell responses against the 4 dengue virus serotypes are associated with distinct patterns of protein targets, J. Infect. Dis., 212, 1743, 10.1093/infdis/jiv289 · DOI · Paper page
  138. Arlehamn, 2014, Transcriptional profile of tuberculosis antigen-specific T cells reveals novel multifunctional features, J. Immunol., 193, 2931, 10.4049/jimmunol.1401151 · DOI · Paper page
  139. Lindestam Arlehamn, 2014, Definition of CD4 immunosignatures associated with MTB, Front. Immunol., 5, 124, 10.3389/fimmu.2014.00124 · DOI
  140. Burel, 2018, Transcriptomic analysis of CD4(+) t cells reveals novel immune signatures of latent tuberculosis, J. Immunol., 200, 3283, 10.4049/jimmunol.1800118 · DOI
  141. Burel, 2019, Host transcriptomics as a tool to identify diagnostic and mechanistic immune signatures of tuberculosis, Front. Immunol., 10, 221, 10.3389/fimmu.2019.00221 · DOI
  142. Grifoni, 2018, Cutting Edge: transcriptional profiling reveals multifunctional and cytotoxic antiviral responses of zika virus-specific CD8(+) T cells, J. Immunol., 201, 3487, 10.4049/jimmunol.1801090 · doi:10.4049/jimmunol.1801090
  143. Tian, 2017, Unique phenotypes and clonal expansions of human CD4 effector memory T cells re-expressing CD45RA, Nat. Commun., 8, 1473, 10.1038/s41467-017-01728-5 · DOI · Paper page
  144. Tian, 2019, Dengue-specific CD8+ T cell subsets display specialized transcriptomic and TCR profiles, J. Clin. Invest., 129, 1727, 10.1172/JCI123726 · DOI
  145. Grifoni, 2020, Transcriptomic immune profiles of human flavivirus-specific T-cell responses, Immunology, 160, 3, 10.1111/imm.13161 · DOI
  146. Tian, 2019, Molecular signatures of dengue virus-specific IL-10/IFN-gamma co-producing CD4 t cells and their association with dengue disease, Cell Rep., 29, 10.1016/j.celrep.2019.11.098 · DOI
  147. Grifoni, 2020, T cell responses induced by attenuated flavivirus vaccination are specific and show limited cross-reactivity with other flavivirus species, J. Virol., 10.1128/JVI.00089-20 · DOI · Paper page

Cited by

See all 81

Metadata

Authors
Sidney, J., Peters, B., & Sette, A.
Venue
Seminars in Immunology
Publisher
Elsevier BV
Published
2020-08
Volume
50
Pages
101418
ISSN
1044-5323
Cited by
81
References
17
Language
en
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Funders
  • National Institute of Allergy and Infectious Diseases (75N93019C00001, U19 AI135731, HHSN272201400045C, 75N9301900065)
  • National Institutes of Health

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Epitope prediction and identification—Adaptive T cell responses in humans. https://app.cochat.ai/papers/10.1016/j.smim.2020.101418
The paper
Sidney, J., Peters, B., & Sette, A. (2020). Epitope prediction and identification—Adaptive T cell responses in humans. Seminars in Immunology. https://doi.org/10.1016/j.smim.2020.101418

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.